Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium Falciparum in Semi-immune Adults
NCT02488902Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Aug 1998
- Primary completion
- Sep 1998
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 2 trial of tafenoquine in malaria, sponsored by U.S. Army Medical Research and Development Command. Started Aug 1998; status: completed.
02
Drugs
tafenoquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02488902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02488902.